APA (7th ed.) Citation

Gross, M. E., Agus, D. B., Dorff, T. B., Pinski, J. K., Quinn, D. I., Castellanos, O., . . . Shih, J. C. (2021). Phase 2 trial of monoamine oxidase inhibitor phenelzine in biochemical recurrent prostate cancer. Prostate cancer and prostatic diseases, 24(1), 61-68. https://doi.org/10.1038/s41391-020-0211-9

Chicago Style (17th ed.) Citation

Gross, Mitchell E., David B. Agus, Tanya B. Dorff, Jacek K. Pinski, David I. Quinn, Olga Castellanos, Patrick Gilmore, and Jean C. Shih. "Phase 2 Trial of Monoamine Oxidase Inhibitor Phenelzine in Biochemical Recurrent Prostate Cancer." Prostate Cancer and Prostatic Diseases 24, no. 1 (2021): 61-68. https://doi.org/10.1038/s41391-020-0211-9.

MLA (9th ed.) Citation

Gross, Mitchell E., et al. "Phase 2 Trial of Monoamine Oxidase Inhibitor Phenelzine in Biochemical Recurrent Prostate Cancer." Prostate Cancer and Prostatic Diseases, vol. 24, no. 1, 2021, pp. 61-68, https://doi.org/10.1038/s41391-020-0211-9.